I N F L A M M AT I O N
An astounding number and diversity of microorganisms coexist with mammalian organisms 1 . Recent years have seen an increase in understanding of the complexity and sophistication of the host-microbiota relationship and its effects on human health [2] [3] [4] . Several technological advances have bolstered the study of mammalian microbiomes. Sequencing of 16S-rRNA-encoding genes has identified the constituent bacterial species of the human intestinal microbiota as belonging predominantly to the Bacteroidetes and Firmicutes phyla. Deep sequencing of the internal-transcribed-spacer regions ITS1 and ITS2 of the fungal ribosomal DNA and improved downstream analyses 5, 6 have unveiled the presence of rich fungal communities, dubbed the mycobiome, within the mammalian intestinal tract 7 . Sequencing of total DNA, the metagenome, from fecal specimens has enabled systematic studies on the virome and has yielded valuable information about the complex interaction of these commensals with their host. Large-scale endeavors have been launched to characterize the human microbiome: the US National Institutes of Health (NIH)-funded Human Microbiome Project (HMP) and the European Metagenomics of the Human Intestinal Tract (MetaHIT) 8, 9 . Concurrently, gnotobiotic resources and treatment of mice with antibiotics have shown how specific compositions of the mouse or human gut microbiota contribute to disease development and have enabled mechanistic dissection of host-microbiota interactions. Targeted phenotypic culturing by subjecting fecal samples to selection for a desired phenotype and subsequent whole-genome sequencing and phylogenetic analysis has revealed that almost 75% of the intestinal microbiota is culturable 10 . Selection for sporulation has indicated that 50-60% of intestinal bacterial genera produce resilient spores adapted for survival and dispersal 10 , thus potentially explaining why, in humans, the intestinal microbiota of family members with close contact have Ruminococcaceae and Lachnospiraceae spore-forming bacteria in common 11 . Ex vivo organ cultures of the mouse intestine have allowed for the introduction of molecules and microbes into the gut lumen in a setting that recapitulates luminal flow and features spontaneous peristaltic-like contractions and an intact tissue architecture and cellular network 12 .
Microbiome-wide studies have revealed important correlations between specific microbes and a range of diseases including inflammatory bowel disease (IBD), autoimmune disease 13 , cancer 14 and metabolic 4 and neurodegenerative disorders 15 . Chronic inflammation is a driver of many of these conditions. Here, we focus on the most recent insights into the molecular underpinnings of host-microbiota interactions that influence inflammation within the intestine and distal organs. We consider the properties of the microbiota that most critically affect the immune response, including its biogeography, metagenome and metabolome, and how the microbiome modulates the host response to infection, autoimmunity, neuroinflammation, vaccination and tumor immunotherapy.
Toward identification of an immune-modulatory microbiota Physical and biochemical barriers anatomically segregate the microbiota from mammalian immune cells in the intestine 3, 16 . This 'demilitarized zone' is essential to limit inappropriate immune activation 16 . On the host side of this zone lies the intestinal epithelium 17 , which comprises a single layer of intestinal epithelial cells whose frequent cycles of apoptosis and renewal 18 maintain cellular fitness and orchestrate intestinal immune homeostasis 19 .
The demilitarized zone is not impermeable, and certain commensals, such as segmented filamentous bacteria (SFB), Acinetobacter spp., Bacteroides fragilis and Proteobacteria, can associate with the intestinal epithelium 20 . Proximity to the epithelium evokes the R e v i e w strongest effects on the host. For example, the capsular polysaccharide A of the human commensal B. fragilis stimulates production of the anti-inflammatory cytokine IL-10 by Foxp3 + regulatory CD4 + T (T reg ) cells, thus facilitating colonization while promoting beneficial immunosuppression in the intestine 20 . Outer-membrane vesicles produced by B. fragilis activate noncanonical autophagy (involving the autophagy-related protein ATG16L1 and the receptor Nod2), thereby inducing T reg cells and suppressing mucosal inflammation 21 . Intestinal SFB colonization induces a response by IL-17-producing helper T (T H 17) cells positive for the transcription factor RORγt, thus protecting mice from infection with the enteric rodent pathogen Citrobacter rodentium 3 . Similarly, Clostridium spp. and the human symbiont Clostridium ramosum are potent inducers of colonic T reg cells 3, 12 . T cell-dependent immunoglobulin A (IgA) production is activated by epithelium-associated commensal bacteria, such as Mucispirillum and SFB 22 . These observations highlight the importance of defining the immunologically relevant microbiome, especially because many of the mucosal responses regulated by the microbiota are critical for intestinal homeostasis and are disrupted in IBD.
The mouse circadian clock is synchronized according to diurnal oscillations in the composition and activities of the microbiota [23] [24] [25] . The numbers and species of epithelial-associated commensals in mice fluctuate almost tenfold in the dark phase compared with the light phase, and diurnal oscillations in species such as Mucispirillum schaedleri, Lactobacillus reuteri and Bacteroides acidifaciens are associated with the feeding cycle 24 . Bacterial adherence to the epithelium controls reprogramming of transcriptional oscillations not only in the colon but also at distant sites, such as the liver, through rhythmic chromatin remodeling and the activity of promoter and enhancer regions 24 . The diurnal detoxification of acetaminophen, regulated by circadian liver functions, is disrupted by changes in the microbiota 24 .
The aforementioned immunologically relevant microbiome includes several keystone pathosymbionts identified through sorting and sequencing of IgA-coated microbiota (a technique termed IgA-seq or Bug-FACS) 22, 26, 27 . During the first two years of life in humans and gnotobiotic mice, age-specific bacterial taxa define distinct temporal patterns of mucosal IgA responses 28 . IgA can crosslink bacteria in the mammalian intestine, thereby inhibiting bacterial pathogenesis or the genetic spread of antimicrobial resistance 29 . Fecal IgA varies independently of bacterial phylogeny and can be perturbed during disease 30 . Enrichment of Enterobacteriaceae and Lachnospiraceae in IgA-coated and IgA-negative microbiota, respectively, in both Crohn's disease-associated spondyloarthritis 31 and malnutrition 26 , suggest that a potential core IgA response may exist in various inflammatory conditions. Keystone pathosymbionts may similarly affect mucosal T cell responses. Human-derived adherent-invasive Escherichia coli and Bifidobacteria adolescentis induce both mucosal and systemic inflammatory T H 17 cells 31, 32 . Although both of these pathosymbionts recapitulate the close epithelial adherence that has been observed for SFB, B. adolescentis triggers an epithelial transcriptional response distinct from that of SFB, thus suggesting the potential for shared and distinct pathways in microbial induction of T H 17 cells. Whereas cluster IV, cluster XIVa and cluster XVIII Clostridium support T reg induction 33 , nearly one-quarter of the 53 species recently profiled similarly induce colonic T reg cells. This potential redundancy by a diverse group of bacteria may serve to ensure consistency in mucosal homeostasis. However, the immunomodulatory properties of different bacterial species do not necessarily cluster by phylum or genus, thus highlighting the importance of considering strain-specific traits when assessing immunological phenotypes.
The subset of microbes that colonize lymphoid tissues are known as lymphoid-tissue-resident commensal (LRC) bacteria and include alpha-and betaproteobacteria, such as Alcaligenes, Achromobacter, Bordetella and Ochrobactrum species [34] [35] [36] [37] . LRC bacteria selectively colonize the Peyer's patches, isolated lymphoid follicles and mesenteric lymph nodes in healthy humans, nonhuman primates and mice, and their entry to these tissues depends in part on M cells, IgA and the cytokine IL- 22 (refs. 34,36,38) . LRC bacteria colonize dendritic cells and uniquely modulate cytokines that promote responses by local T H 17 cells and group 3 innate lymphoid cells (ILC3) 34 . Innate lymphoid cells are ubiquitously distributed in humans and mice but are enriched at mucosal surfaces and rapidly respond to cytokine milieus after colonization with microbes 37 . Among subsets of innate lymphoid cells, ILC3 are most heterogeneous, uniquely express RORγt and broadly comprise two subsets on the basis of expression of the chemokine receptor CCR6 or the transcription factor T-bet. CCR6 + ILC3 lymphoid-tissue-inducer-like cells persist after birth in secondary lymphoid tissues, cryptopatches and isolated lymphoid follicles. CCR6 + ILC3 promote gut-associated lymphoid-tissue maturation and IgA production, and contribute to the innate host defense to enteric pathogens 37 . CCR6 + ILC3 are also antigen-presenting cells that regulate homeostasis with beneficial microbes by limiting the development of microbiota-specific CD4 + T cell-effector responses in the intestine 37 . In contrast, T-bet + ILC3 are localized diffusely in the intestinal lamina propria, require the aryl hydrocarbon receptor (AHR) and expand after microbiota colonization 37, 39 . AHR protects mucosal sites from pathogenic infection and inflammation 40 . T-bet + ILC3 are responsive to microbial sensing by mononuclear phagocytes positive for the chemokine receptor CX3CR1, and subsequent ILC3 production of IL-22 has been linked to intestinal-tissue repair and barrier function by acting directly on intestinal epithelial stem cells 37, 41 . IL-22 production by ILC3 also regulates epithelial fucosylation and supports diverse microbiota colonization 37 .
LRC bacteria also induce IL-10 production by dendritic cells and provide tissue-protective functions in the context of intestinal-barrier damage 34 . ILC3 promote anatomical containment of LRC bacteria, because ILC3 depletion results in systemic bacterial dissemination and chronic immunological activation 37 . Additional research is required to define the mechanisms by which LRC bacteria colonize dendritic cells and mammalian lymphoid tissue, as well as to interrogate the functional potential and compositional changes of LRC bacteria in the context of chronic inflammatory diseases.
Interaction with symbiotic fungi, protozoa, worms and viruses Rich and diverse fungal communities (mycobiota) colonize the mammalian barrier surfaces. Mycobiota diversity increases in the lower gastrointestinal tract, and several genera such as Candida, Saccharomyces, Aspergillus, Cryptococcus, Malassezia, Cladosporium, Galactomyces and Trichosporon have the potential to colonize the intestines 7, [42] [43] [44] . Fungal-community changes with outgrowth of Candida spp. have been documented in people with IBD 43, [45] [46] [47] . Deficiencies in the receptor Dectin-1 (also known as CLEC7A) and the downstream adaptor protein CARD9 lead to susceptibility to more severe experimental colitis as well as fungal and bacterial dysbiosis 6, 7, 48 . Clec7a -/-mice colonized with Candida tropicalis show aggravated experimental colitis, whereas the absence of Candida leads to less severe disease 6, 49 . Fungi and bacteria share similar niches in the intestine, and these communities influence each other. Antibiotic treatment promotes gut Candida colonization 7, 50 , which can have immunological outcomes at distant sites such as the lung 7, 51 . Bacteria affect fungal colonization both directly and indirectly. Bacteroidetes thetaiotamicron, which induces the production of the antimicrobial peptide CRAMP by the transcription factor HIF-1α, prevents Candida albicans gut colonization 52 . In addition to fungi, the common mouse protozoan Tritrichomonas musculis is a transmissible microorganism in mice that increases susceptibility to T cell-dependent intestinal inflammation while providing protection from intestinal infections through inflammasome activation and production of the cytokine IL-18 by intestinal epithelial cells 53, 54 .
The mammalian gastrointestinal tract is also colonized with eukaryotic viruses, which may substantially affect intestinal health and disease. Colonization with common murine norovirus is able to compensate for several, but not all, functional and immunological defects in germ-free or antibiotic-exposed mice 55 . In the presence of a diverse microbiota, several enteric eukaryotic viruses interact with the commensal microbiota and consequently induce immunologicalevasion pathways and ensure their own replication and transmission 56, 57 . Although the contributions of colonizing eukaryotic viruses and bacteriophages to human health are only beginning to be interrogated, early analyses have suggested substantial changes in these populations in the context of IBD and progressing HIV infection [58] [59] [60] . Finally, intestinal worms or helminths have long been known to influence intestinal immune responses and physiology, and may be an ancient intestinal symbiont lost in industrialized nations. In the developing world, helminths affect bacterial composition and colonization resistance 61 , and independently impair host immunity to eukaryotic viruses 62, 63 through induction of intestinal type 2 immune responses. These data highlight intestinal symbionts other than bacteria and the importance of considering multiple cross-kingdom interactions in future basic and translational studies of the microbiota.
Microbiota small molecules mediate interspecies interaction
The gut microbiota is influenced in part by long-term dietary habits and is responsive to daily variations in food 4 , and it contributes to the metabolite profile in the plasma 64 . Bacterial metabolites exhibit rhythmicity, owing to the oscillation of several bacterial biosynthetic pathways, such as those for biotin and proline 24 . Concordantly, homeostatic circadian oscillations in the serum levels of amino acids and polyamines are sensitive to dysbiosis and dietary polyamine content 24 . Dietary-fiber deficiency promotes the proliferation of mucus-degrading bacteria, thus leading to colonic mucus erosion, association of luminal bacteria with the intestinal epithelium and increased susceptibility to Citrobacter 65 (Fig. 1) . Short-chain fatty acids (SCFA) derived from the anaerobic fermentation of nondigestible polysaccharides such as dietary fiber, particularly by Clostridia spp., counter inflammation and maintain gut homeostasis 66 (Fig. 1) . Among SCFAs, butyrate uniquely inhibits intestinal stem-cell and progenitorcell proliferation during mucosal injury, and this inhibition is likely to prevent their potential transformation under genotoxic stress in response to luminal contents 67 . Colonocyte localization at the crypt mouth ensures the preferential consumption of butyrate before it reaches stem cells at the crypt base 67 (Fig. 1) . Microbiota-derived butyrate promotes colonic oxygen consumption stabilizing the transcription factor HIF-1 and its target barrier-protective genes 68 .
Gut bacteria are also an important source of potent antiinflammatory polyamines such as putrescine and spermine. Ingestion of the probiotic Bifidobacteria LKM512 by elderly people increases intestinal polyamine concentrations and inhibits intestinal inflammation, particularly when it is administered with arginine 69 . Importantly, microbiota-derived histamine, putrescine and spermine suppress cleavage of the protease caspase-1 and secretion of IL-18 as well as the colonic expression of antimicrobial peptides that predispose the colon to inflammation 70 (Fig. 2) . The suppressive activity of these polyamines is countered by the bile-acid conjugate taurine, which induces activation of the NLRP6 inflammasome and production of IL-18 after intestinal microbial colonization and promotes microbial diversity and intestinal homeostasis 70 (Fig. 2) .
In humans, specific bacteria such as Lactobacilli spp. metabolize dietary tryptophan, thus generating indole ligands for AHR 40 . These ligands can also be derived from the breakdown of glucosinolate glucobrassicin from cruciferous vegetables 40 . Lactobacillus production of AHR ligands promotes resistance to intestinal colonization by C. albicans 71 . The intestinal microbiota of Card9 -/-mice has altered Lactobacilli populations, thus leading to impaired tryptophan metabolism, defective production of AHR ligands and decreased gut expression of IL-22 and the antimicrobial proteins Reg3γ and Reg3β (ref. 48 ). AHR activity is controlled by the cytochrome P4501 enzymes, which terminate AHR signaling by metabolizing AHR ligands 72 . Constitutive expression of cytochrome P450 1A in mice or its specific deletion in intestinal epithelial cells deprives T H 17 and ILC3 of AHR ligands, thus leading to the loss of these cell populations from the intestine as well as to increased susceptibility to C. rodentium; however, these effects are reversed by dietary supplementation with AHR ligands 72 .
Trimethylamine-N-oxide generated through the metabolism of diet-derived choline, phosphatidylcholine and carnitine, sequentially by gut microbes and the liver, increase platelet hyper-responsiveness and thrombosis risk 73 and accelerate heart and liver disease [74] [75] [76] . Despite abundant representation of the glycyl radical enzyme (GRE) superfamily that catalyze this enzymatic conversion by the human microbiota, little is known about the activity and roles of GREs in health and disease. The use of chemically guided functional profilingcoupled protein sequence-similarity networks combined with quantitative metagenomics has allowed for the discovery and functional characterization of trans-4-hydroxy-l-proline dehydratase 77 , the most abundant GRE in the NIH HMP stool microbiota. This enzyme allows the microbiota to chemically reverse C4-hydroxylation of l-proline (the most common eukaryotic post-translational modification), thereby acquiring additional sources of carbon and nitrogen (Fig. 2) . Chemically guided functional profiling has also led to the functional characterization of novel coenzyme B 12 -independent propanediol dehydratase, which converts l-fucose to SCFA (Fig. 1) . Although propanediol dehydratase might be the major contributor to propionate production at steady state, coenzyme B 12 -dependent propanediol dehydratase is required for T H 17 induction by adherent-invasive E. coli 31 .
A survey of biosynthetic-gene clusters from stool samples from the NIH HMP has identified thousands of biosynthetic loci with no known functions 78 . Nonribosomal peptide synthetase-encoding gene clusters have been identified as an abundant gene cluster exclusive to gut-associated bacterial species, predominantly in anaerobic Firmicutes from the class Clostridia, and several clusters in Gramnegative Bacteroides and Desulfovibrio 78 . Their absence in free-living or nonintestinal niche-colonizing microorgansims suggests adaptation to intestinal colonization 79 . Heterologous expression combined with quantitative and unbiased chemical proteomics has led to the discovery of dipeptide aldehydes 79 . The dipeptide aldehyde PhePhe-H is stable and acts as a cell-permeable inhibitor of cathepsins (Fig. 2) , thus suggesting active blockade of innate and adaptive immunity by microbiota-derived dipeptide aldehydes, given that cathepsins are important for antigen processing and presentation, as well as endosomal activation of the Toll-like receptor TLR9 (ref. 80 ). There is great potential for the discovery of novel mechanisms of immune modulation through the functional characterization of yet-undiscovered microbiota-derived molecules.
R e v i e w
Gut microbiota modulate inflammation at distant sites Both bacterial and fungal dysbiosis have been linked to autoimmune and immune-mediated diseases 13, 51, 81 . The prevalence of Bacteroides spp. within Finnish and Estonian infants is associated with early-onset autoimmune disease 82 (Fig. 3) . Relative to Russia, Finland has an incidence two-to sixfold higher for allergies and five-to sixfold higher for type 1 diabetes and other autoimmune disorders. Compared with the hexa-acylated lipopolysaccharide (LPS) expressed by the more abundant E. coli in Russian infants, the less stimulatory tetra-and penta-acylated LPS characteristic of Bacteroides spp. impairs endotoxin tolerance, thereby leading to a propensity for higher immunological stimulation 82 (Fig. 3) . These data are concordant with the hygiene hypothesis, in which early-life exposure to specific microbes and parasites confers protection against allergic and autoimmune disease 83, 84 , and they highlight how perinatal environmental influences on the microbiota can determine susceptibility to immune-mediated disease later in life.
The effects of commensal microbiota on mucosal and systemic immunity highlight a potential role for keystone species in autoimmunity. Antigen-specific T H 17 responses develop to the intestinal microbiota in mice 3 and in people with Crohn's disease 85 as well as to the intestinal epithelium during mouse colonic infection associated with apoptosis of intestinal epithelial cells 86 . Severe gastrointestinal infection in mice leads to loss of T cell tolerance to commensal antigens and results in long-lived inflammatory effector T cells that drive chronic intestinal and extraintestinal inflammatory pathology 87 . In mice, infection-induced apoptosis of intestinal epithelial cells triggers the loss of CD4 + T cell tolerance to self-antigen derived from intestinal epithelial cells. Under these conditions, self-reactive CD4 + T cells differentiate into T H 17 cells alongside pathogen-specific CD4 + T cells and mediate intestinal inflammation 86, 88 . Notably, the T H 17 response to SFB is not disrupted by concurrent infection with the T H 1-cell inducer Listeria monocytogenes 89 . SFB-induced T H 17 cells are sufficient to induce extraintestinal inflammatory disease including inflammatory joint disease 90 and experimental autoimmune encephalomyelitis 91 .
A role for mucosa-associated microbiota is coming to light in systemic autoimmunity. IgA-coated mucin-degrading Akkermansia muciniphila are enriched in an HLA-B27-antigen transgenic rat model of inflammatory arthritis 92 . An enrichment in adherent-invasive E. coli in the IgA-coated microbiota has also been found in people with Crohn's disease-associated spondyloarthritis, and this observation correlates with systemic T H 17 cell activation and E. coli seroreactivity 31 (Fig. 3) . Adherent and invasive bacteria are enriched in ileal biopsies from people with HLA-B27 + ankylosing spondylitis 93 . Figure 1 Dietary fiber and SCFAs in intestinal homeostasis. Anaerobic fermentation of dietary fiber by members of the commensal microbiota, particularly by Clostridia spp., serves as a source of SCFAs, which help to maintain T reg cell expansion, immunosuppressive function and overall intestinal homeostasis. Butyrate is the preferred metabolic energy source for colonocytes but is detrimental to stem cells, inhibiting their proliferation and wound-repair functions 67 . The strategic positioning of colonocytes and stem cells within the colon mirrors the concentration gradient of butyrate: colonocytes are positioned at the location of highest concentrations near the lumen, where they consume butyrate, thus decreasing the concentration to which distally located stem cells within the colonic crypts are exposed. Propionate is the end product of fucose metabolism by the microbiota. The host increases fucosylation of epithelial-cell carbohydrates during infection, thereby protecting its gut commensals 116 . Fucose-using B. acidifaciens increase in abundance and elevate their metabolism of fucose, thus leading to propanediol formation. Propanediol dehydratase converts propanediol to propionaldehyde, thereby generating propionic acid 77 , which in turn tempers inflammation and protects host tissues from collateral damage during the immune response to infection. gut microbiota to regulate systemic autoimmunity 94 , but additional models are needed to understand the contribution of microbe-specific autoimmunity to the pathophysiology of inflammatory disease.
Induction and egress of intestinal T follicular helper cells enable the
Both the gut microbiome and the immune system are integral parts of gut-brain communication, which relies on neuroendocrine and autonomic nervous systems 95, 96 . Enteric afferent neurons communicate intestinal conditions to intestinal muscularis macrophages via β2-adrenergic receptors 97 and to the brain through the vagus nerve 95, 96 . Intestinal infections of mice with C. rodentium, Campylobacter jejuni or Salmonella enterica var. Typhimurium increase levels of the transcription factor c-Fos in visceral and vagal neurons in select brain regions, events requiring an intact vagus nerve 98 . Multiple members of the microbiota such as Escherichia, Lactobaccillus, Bifidobacterium, Enterococcus and Truchuris produce neurotransmitters and neuropeptides including dopamine, acetylcholine, gamma-aminobutyric acid, serotonin (5-hydroxytryptamine) and brain-derived neurotrophic factor 98 (Fig. 4) . These metabolites induce mouse intestinal epithelial cells to release molecules that modulate signaling within the enteric nervous system. Spore-forming bacteria, primarily Clostridium spp., modulate the colonic luminal metabolome, including SCFAs, thereby inducing serotonin biosynthesis by enterochromaffin cells-the major producers of serotonin-and consequently affecting intestinal motility and platelet function in mice 99, 100 (Fig. 4) . Serotonin has a wide range of physiological effects including the development and function of the immune system 101 , and it will be important to determine its role in intestinal inflammation and to elucidate how serotonin control by the microbiota affects function and inflammation in distal tissues including the brain. Microbiota-dependent signals also stimulate entericnervous-system nociceptors known to regulate inflammation 12 . Immunomodulatory colonic RORγt + T reg -inducing C. ramosum represses neuronal-specific transcripts, particularly those encoding Together, these signals activate the NLRP6 inflammasome in intestinal epithelial cells and lead to the production of epithelial IL-18 and downstream antimicrobial peptides (AMP). Under dysbiotic conditions, such as those in mice lacking the inflammasome adaptor ASC, microbiota-derived histamine, putrescine and spermine are increased, thus suppressing NLRP6 inflammasome signaling in intestinal epithelial cells, decreasing production of epithelial IL-18 and AMP in the colon and promoting intestinal inflammation 70 . B. thetaiotamicron induces the transcription factor HIF-1α in intestinal epithelial cells, thereby activating transcription and production of the antimicrobial peptide LL-37 (CRAMP in mice), which in turn promotes resistance to C. albicans colonization 52 . Gut anaerobic Firmicutes from the class Clostridia, and several clusters in Gram-negative Bacteroides and Desulfovibrio, express nonribosomal peptide synthetase-encoding gene clusters that mediate the synthesis of dipeptide aldehydes 79 . The dipeptide aldehyde Phe-Phe-H is cell permeable and has been shown to inhibit cathepsins in macrophages, an activity that might modulate antigen processing and innate immune function 79 . The generation of the nonproteinogenic amino acid trans-4-hydroxy-l-proline (t4L Hyp) is one of the most common post-translational modifications in eukaryotic cells but is rare in bacteria. Intestinal commensals such as Clostridiales and human pathogens such as C. difficile chemically reverse proline hydroxylation through the activity of the GRE trans-4-hydroxy-l-proline dehydratase, which generates l-proline 77 . Many Clostridiales then use l-proline as an electron acceptor in amino acid fermentation.
R e v i e w nociceptive neuropeptides, in microfluidics-supported mouse intestinal organ cultures (Fig. 4) , thus suggesting an unappreciated inverse functional link between neuronal activation and T reg cell differentiation 12 .
The blood-brain barrier and brain lymphatic vasculature allow the passage of various immune cells, macromolecules and metabolites into the brain 96 . Disruption or absence of the microbiota in mice impairs the function of the blood-brain barrier (Fig. 4) , alters cortical myelination and hippocampal neurogenesis, decreases cognitive function and memory formation, and decreases social and anxiety-like behavior 96 . Microbiota-derived SCFAs promote the differentiation and function of microglia, the resident macrophages in the brain 102, 103 (Fig. 4) , and play a significant role in accelerating the appearance of motor deficits mediated by the neuronal protein α-synuclein as well as brain pathology in a mouse model of Parkinson's disease 104 . Gut microbiota from people with Parkinson's disease induce enhanced motor dysfunction when they are transplanted into α-synuclein transgenic mice 104 , thus suggesting that Parkinson's disease-associated microbes can trigger disease symptoms in this genetically susceptible mouse model. However, microbiota-dependent metabolism of tryptophan into AHR ligands targets AHR on astrocytes, which are critical in neuronal transmission and development and repair of the central nervous system, thereby limiting central-nervous-system inflammation in mice 105 (Fig. 4) . Dietary supplementation with tryptophan ameliorates autoimmune encephalomyelitis scores, whereas treatment of mice with ampicillin worsens disease 105 .
Microbiota-driven modulation of the host immune response
Significant associations between fungal-and bacterial-induced cytokine responses and specific gut bacterial species and genera have been found through the Human Functional Genomics Project 106 . For example, production of the cytokines IFN-γ and TNF by peripheral blood mononuclear cells is more strongly associated with the microbiome than are the cytokines IL-6 and T H 17-derived IL-17 and IL-22. Staphylococcus aureus-induced IL-17 is positively associated with five genera, including species from Clostridium clades IV and XIV, and is negatively associated with Fecalibacterium, including Fecalibacterium prausnitzii; however, multiple diet-sensitive bacteria, such as Alistipes spp., Clostridium spp. and Bilophila spp., are negatively associated with LPS-induced TNF production 106 . Although these findings have identified targetable regulators of systemic inflammation, analysis of the metabolic pathways and gene-ontology categories explaining the cytokine variation has indicated that microbiome functions have a greater effect on the cytokine response than do taxonomic classifications; for example, IFN-γ and TNF are strongly modulated by microbial palmitoleic acid metabolism and degradation of tryptophan to tryptophol 106 .
Microbiota-driven variations in the inflammatory response have been predicted to regulate the host response to infection 106 . The intestinal microbiota can mediate colonization resistance against enteric pathogens. The conversion of primary to secondary bile salts in Clostridium scindens is associated with resistance to Clostridium difficile infection in mice and humans 107 . In Caenorhabditis elegans, the peptidoglycan hydrolase activity of the secreted antigen A from the commensal Enterococcus faecium protects against Salmonella pathogenesis 108 . In Drosophila, gut-microbiota-derived peptidoglycans, particularly from the commensal Acetobacter pomorum, prime intestinal induction of a secreted factor that is released after enteric viral infection and stimulates antiviral signaling by extracellularsignal-regulated kinases in intestinal epithelial cells 109 . Colonization resistance by the intestinal microbiota can be extended to systemic infections or pathogens infecting distant sites such as the lung. In the absence of the microbiota, hematopoietic defects in tissueresident myeloid cells confer susceptibility to intravenous infection with L. monocytogenes 110 . Gut-microbiota-derived products preprime inflammasome-dependent cytokines that promote dendriticcell migration from the lung during respiratory influenza A virus infection 111 and enhance innate immune responses of neutrophils in a manner dependent on the receptor Nod1 (ref. 112). The protection afforded by intestinal microbiota against enteric pathogens such as C. difficile has paved the way toward therapeutic development of probiotics that enhance host resistance against life-threatening antibioticresistant pathogens, such as vancomycin-resistant enterococci. These bacteria expand not because of their antibiotic resistance but because the antibiotic kills the protective commensal bacterial species that provide colonization resistance 113 .
Beyond conferring resistance, endosymbionts confer disease tolerance to infection in insects and in mice 114 . Disease tolerance does not target the infecting pathogen but instead protects against Figure 3 Associations between the intestinal microbiota and autoimmune disorders. Infants from Russia have more abundant E. coli species expressing stimulatory hexa-acylated LPS, whereas infants from Finland and Estonia have more abundant Bacteroides spp. expressing the less stimulatory tetra-and penta-acylated LPS 82 . Hexa-acetylated LPS induces greater Immunological stimulation but also endotoxin tolerance thought to dampen the capacity for immunological education in early life. However, the less stimulatory LPS from Bacteroides spp. impairs LPS tolerance, thus increasing susceptibility to immunological disease later in life. Enrichment of adherent-invasive E. coli in the IgA-coated microbiota in patients with Crohn's disease-associated spondyloarthritis correlates with E. coli seroreactivity and systemic T H 17 cell activation 31 .
physiological damage such as cachexia, muscle wasting or endotoxic shock in response to infection 114 . The endosymbiont E. coli O21:H + protects mice against muscle wasting and loss of fat during enteric S. Typhimurium or respiratory Burkholderia thailandensis infections by activating the NLRC4 inflammasome 115 . Subsequent IL-18 sustains production of the growth factor IGF-1, which in turn activates signaling by the PI3K-AKT kinase pathway in skeletal muscle, thereby countering muscle wasting 115 . Increased fucosylation of the intestinal epithelium during systemic exposure to Toll-like-receptor ligands is sensed by the intestinal microbiota, thus leading to an abundance of fucose-using B. acidifaciens 116 (Fig. 1) . Fucose is a substrate for microbial production of propionate 117 and may thus promote hostprotective SCFA-mediated effects. This adaptation of the intestinal microbiota to conditions of host stress confers host tolerance to C. rodentium but notably without affecting colonic bacterial burdens 116 . The microbiota can also contribute to negative outcomes after acute infection with Yersinia pseudotuberculosis, in which sustained intestinal inflammation and lymphatic leakage after pathogen clearance is mediated by the microbiota 118 . Distinct readouts are necessary to identify whole-microbiome associations with interindividual variations in disease tolerance. Evidence in mice has suggested that the microbiota can modulate vaccine responses. Differentiation of T follicular helper cells and plasma cells in response to intranasal immunization is promoted by the nasal microbiota of mice, particularly Staphylococcus sciuri, via signaling by Nod2 and the kinase RIPK2 in CD11c + phagocytes 119 . Toll-like-receptor stimulation by microbiota-derived signals conditions IgA class-switching in mouse-lung CD103 + dendritic cells after intranasal immunization 120 . Treatment of mice with antibiotics diminishes specific antibody and CD8 + T cell responses to a trivalent Figure 4 Links between the intestinal microbiota and neuroinflammation. Multiple members of the microbiota, such as Escherichia, Lactobaccillus, Bifidobacterium, Enterococcus and Truchuris, produce neurotransmitters and neuropeptides including dopamine, acetylcholine, gamma-aminobutyric acid, serotonin and brain-derived neurotrophic factor 98 . Spore-forming bacteria, primarily Clostridium spp., modulate the colonic luminal metabolome, including SCFAs, thus inducing serotonin biosynthesis by enterochromaffin cells-the major producers of serotonin-and thereby affect intestinal motility and platelet function in mice 99, 100 . In the colon, C. ramosum induces RORγt + T reg cells but also represses neuronal-specific transcripts, particularly those encoding nociceptive neuropeptides 12 . Afferent neurons within the enteric nervous system (ENS) can communicate intestinal conditions to intestinal muscularis macrophages via β2-adrenergic receptors 97 and also to the brain via the vagus nerve 95, 96 . Intestinal colonization by the microbiota increases blood-brain tight junctions and barrier function, although microbiota-derived SCFAs can gain access to the brain and promote microglia differentiation and function 102, 103 . Microbiota-dependent metabolism of tryptophan into AHR ligands engages AHR on astrocytes, thus leading to an increase in astrocyte expression of the inhibitor protein SOCS2 and consequently inhibiting activation of the transcription factor NF-κB and thereby limiting inflammation 105 .
R e v i e w inactivated influenza vaccine 111, 121 . Sensing of the microbiota by the Toll-like receptor TLR5 promotes plasma-cell differentiation after parenteral administration of trivalent inactivated influenza vaccine, probably through flagellin detection 121 . In humans, early TLR5 expression directly correlates with the magnitude of the antibody response to the trivalent inactivated influenza vaccine 122 . Numerous vaccines and boosters are administered to children within the first 15 months of life, when the microbiota is highly sensitive to environmental factors such as hygiene, breast milk versus formula diet, and vaginal versus Caesarean-section delivery 123, 124 . Emerging considerations in determining vaccination efficacy are the microbiota composition and diversity, as well as the therapeutic potential of the critical perinatal period to imprint protective host defenses in adult life. A concomitant assessment of the microbiome in prospective vaccination studies in babies and older humans will be necessary to establish and mechanistically understand the link between commensal microbial communities and vaccine effectiveness. The microbiota plays a complex role in modulating both pro-and antitumor responses. Microbial translocation and chronic inflammation secondary to the loss of intestinal barrier function enhances intestinal tumor progression 125, 126 and may account for an increased risk of colorectal cancer in people with IBD 127 . Inflammation also facilitates the expansion of microbes with oncogenic potential, including Fusobacterium nucleatum, enterotoxigenic B. fragilis or genotoxic E. coli [128] [129] [130] . The microbiota is also essential for the efficacy of antitumor immunity after chemotherapy or immunotherapy 14, 131 . In mouse models, antitumor immunity induced by chemotherapy or blockade with antibodies to the checkpoint inhibitors CTLA-4 and PD-1 is abrogated after dysbiosis or in the absence of intestinal microbiota. Chemotherapy and checkpoint-inhibitor blockade may induce microbial translation or outgrowth of immunostimulatory microbiota such as Bacteriodes or Bifidobacterium species, which can enhance dendritic-cell function and tumor-specific CD8 + T cell responses 132, 133 . These data are provocative and suggest that in some contexts, modulating the microbiota may enhance cancer immunotherapies.
Perspectives and future directions
Host and commensal microbiota interactions follow rules of engagement different from those between host and pathogen. Future studies will undoubtedly yield exciting new insights into how the commensal microbiota modulate immune-cell function and inflammation within the intestine and at distal-tissue sites. It will be important to gain a full understanding of the composition and characteristics of the microbiome that affect vaccine efficacy as well as modulate susceptibility not only to IBD but also to neurological, metabolic and autoimmune diseases. More studies are also needed to define the microbiota constituents that promote health as well as the environmental factors early in life that favor colonization with such microbiota. Such studies should inform new approaches for manipulating the microbiome to alter disease susceptibility and improve vaccine efficacy.
